Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | TYR | P14679 | 1/20 | 0.39 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | PHGDH | O43175 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11327830 | 0.83 | ALDH1A1 (0.41) | ALDH1A1TSHRTP53TYRTAS2R38 | |
| Quinoline SCHEMBL29113163 | 0.82 | ALDH1A1 (0.47) | ALDH1A1TSHRTP53HSD17B10MEN1 | |
| Quinoline SCHEMBL29113171 | 0.81 | ALDH1A1 (0.46) | ALDH1A1TSHRTP53HSD17B10MEN1 | |
| SCHEMBL28966867 | 0.79 | ALDH1A1 (0.54) | ALDH1A1TSHRTP53TYRTAS2R38 | |
| SCHEMBL1067570 | 0.79 | NPSR1 (0.41) | ALDH1A1TSHRHSD17B10L3MBTL1MEN1 | |
| Carbamic Acid SCHEMBL1013200 | 0.78 | NPSR1 (0.40) | ALDH1A1TSHRHSD17B10L3MBTL1MEN1 | |
| SCHEMBL28067711 | 0.75 | L3MBTL1 (0.39) | ALDH1A1TSHRTP53TYRTAS2R38 | |
| SCHEMBL1008397 | 0.74 | NPSR1 (0.44) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL9505610 | 0.73 | NPSR1 (0.40) | ALDH1A1TSHRL3MBTL1MEN1KMT2A | |
| SCHEMBL3776839 | 0.73 | ALDH1A1 (0.47) | ALDH1A1TSHRL3MBTL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117126181-A | Trifluoromethyl phenylthiourea-quinoline copper complex with tumor autophagy induction effect, and preparation method and application thereof | 河南城建学院 | 2023-11-28 | — | — | CN | claimed |
| CN-120413795-A | Application of trifluoromethyl phenylthiourea in lithium-sulfur battery electrolyte, application of lithium-sulfur battery electrolyte and lithium-sulfur battery | 内蒙古民族大学 | 2025-08-01 | — | — | CN | disclosed |
| CN-120413795-A | Application of trifluoromethyl phenylthiourea in lithium-sulfur battery electrolyte, application of lithium-sulfur battery electrolyte and lithium-sulfur battery | 内蒙古民族大学 | 2025-08-01 | — | — | CN | disclosed |
| CN-118027038-A | Hydrogen-bond-assisted chiral dicycloimidazole organic micromolecular catalyst and synthesis method thereof | 上海交通大学 | 2024-05-14 | — | — | CN | disclosed |
| CN-117126181-A | Trifluoromethyl phenylthiourea-quinoline copper complex with tumor autophagy induction effect, and preparation method and application thereof | 河南城建学院 | 2023-11-28 | — | — | CN | disclosed |
| CN-117126181-A | Trifluoromethyl phenylthiourea-quinoline copper complex with tumor autophagy induction effect, and preparation method and application thereof | 河南城建学院 | 2023-11-28 | — | — | CN | disclosed |
| CN-117126181-A | Trifluoromethyl phenylthiourea-quinoline copper complex with tumor autophagy induction effect, and preparation method and application thereof | 河南城建学院 | 2023-11-28 | — | — | CN | disclosed |
| CN-115003666-A | Pesticidally active fused bicyclic heteroaromatic amino compounds | 先正达农作物保护股份公司 | 2022-09-02 | — | — | CN | disclosed |
| EP-2550266-B1 | HETEROCYCLIC COMPOUNDS USEFUL FOR KINASE INHIBITION | AMITECH THERAPEUTICS SOLUTIONS INC (US) | 2018-05-09 | — | — | EP | disclosed |
| CN-107954880-A | Organometallic catalytic for asymmetric transformation | 新泽西鲁特格斯州立大学 | 2018-04-24 | — | — | CN | disclosed |
| US-9212151-B2 | Heterocyclic compounds useful for kinase inhibition | AMITECH THERAPEUTIC SOLUTIONS, INC. (US) | 2015-12-15 | — | — | US | disclosed |
| US-20150158828-A1 | Heterocyclic Compounds Useful for Kinase Inhibition | AMITECH THERAPEUTIC SOLUTIONS, INC. | 2015-06-11 | — | — | US | disclosed |
| US-20140296268-A1 | THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ALLOSTERIC KINASE INHIBITION | AMITECH THERAPEUTIC SOLUTIONS, INC. | 2014-10-02 | — | — | US | disclosed |
| CN-103237853-A | The use of aryl or heteroaryl substituted dithiolene metal complexes as ir absorbers | BASF SE | 2013-08-07 | — | — | CN | disclosed |
| EP-2550266-A2 | HETEROCYCLIC COMPOUNDS USEFUL FOR KINASE INHIBITION | Amitech Therapeutics Solutions, Inc. (US) | 2013-01-30 | — | — | EP | disclosed |
| CN-101921376-B | Chiral three-component polymer with recognition capability, preparation and application thereof | UNIV WUHAN TECH | 2012-04-04 | — | — | CN | disclosed |
| WO-2011119894-A2 | HETEROCYCLIC COMPOUNDS USEFUL FOR KINASE INHIBITION | KINAGEN, INC (US) | 2011-09-29 | — | — | WO | disclosed |
| CN-101921376-A | Chiral three-component polymer with recognition capability, preparation and application thereof | UNIV WUHAN TECH | 2010-12-22 | — | — | CN | disclosed |
| US-7696238-B2 | Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics | GRUENENTHAL GMBH (DE) | 2010-04-13 | — | — | US | disclosed |
| US-20080176915-A1 | Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics | GRUENENTHAL GMBH (DE) | 2008-07-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080176915-A1 | Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics | KCNQ1, KCNQ2, KCNQ3 | ALDH1A1 1965/4885TSHR 4442/4885TP53 4784/4885 |
| US-20150158828-A1 | Heterocyclic Compounds Useful for Kinase Inhibition | MAP4K2, MAP3K20, MAP3K19 | ALDH1A1 3693/4885TSHR 3749/4885TP53 822/4885 |
| US-20140296268-A1 | THERAPEUTIC METHODS AND COMPOSITIONS INVOLVING ALLOSTERIC KINASE INHIBITION | TIE1, PRKCH, PACSIN2 | ALDH1A1 4807/4885TSHR 3656/4885TP53 505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.